National Research Program
The Leukaemia Foundation is committed to funding research innovations that drive rapid advancements in treatments, discover new diagnostics and novel therapies and enable Australian patients to access global clinical trials.
Our overarching aim is to fund high-impact research by concentrating our resources on projects with broad potential for all people living with blood cancer.
We have turned our attention to investment in innovation: in diagnosis, treatments and improving quality of life across the blood cancer spectrum.
The Leukaemia Foundation has been supporting Australian blood cancer research for over 20 years, committing $57.8 million to research since 2000.
Our National Research Program has the following research priorities:
- Understanding the biology of cancers
- Precision medicine – investing in new therapies that are tailor-made to treat each patient’s cancer
- New diagnostics
- Novel therapies and care options
- Psychosocial aspects of cancer
- Innovative clinical trials and/or incorporation of real-world data
- Prevention research including investigating blood cancer risk factors
Under the new National Research Program, we have the following funding mechanisms:
Last updated on December 20th, 2022
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.